Report Detail

Other Global RNAi Technologies Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4600308
  • |
  • 02 July, 2024
  • |
  • Global
  • |
  • 84 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global RNAi Technologies market size was valued at USD 310 million in 2023 and is forecast to a readjusted size of USD 424.5 million by 2030 with a CAGR of 4.6% during review period.
RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
The Global Info Research report includes an overview of the development of the RNAi Technologies industry chain, the market status of Research (Oncology, Ocular Disorders), Therapeutics (Oncology, Ocular Disorders), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of RNAi Technologies.
Regionally, the report analyzes the RNAi Technologies markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global RNAi Technologies market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the RNAi Technologies market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the RNAi Technologies industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncology, Ocular Disorders).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the RNAi Technologies market.
Regional Analysis: The report involves examining the RNAi Technologies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the RNAi Technologies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to RNAi Technologies:
Company Analysis: Report covers individual RNAi Technologies players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards RNAi Technologies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research, Therapeutics).
Technology Analysis: Report covers specific technologies relevant to RNAi Technologies. It assesses the current state, advancements, and potential future developments in RNAi Technologies areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the RNAi Technologies market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
RNAi Technologies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
Market segment by Application
Research
Therapeutics
Market segment by players, this report covers
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe RNAi Technologies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNAi Technologies, with revenue, gross margin and global market share of RNAi Technologies from 2019 to 2024.
Chapter 3, the RNAi Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and RNAi Technologies market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNAi Technologies.
Chapter 13, to describe RNAi Technologies research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of RNAi Technologies
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of RNAi Technologies by Type
    • 1.3.1 Overview: Global RNAi Technologies Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global RNAi Technologies Consumption Value Market Share by Type in 2023
    • 1.3.3 Oncology
    • 1.3.4 Ocular Disorders
    • 1.3.5 Respiratory Disorders
    • 1.3.6 Liver Diseases
    • 1.3.7 Other
  • 1.4 Global RNAi Technologies Market by Application
    • 1.4.1 Overview: Global RNAi Technologies Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Research
    • 1.4.3 Therapeutics
  • 1.5 Global RNAi Technologies Market Size & Forecast
  • 1.6 Global RNAi Technologies Market Size and Forecast by Region
    • 1.6.1 Global RNAi Technologies Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global RNAi Technologies Market Size by Region, (2019-2030)
    • 1.6.3 North America RNAi Technologies Market Size and Prospect (2019-2030)
    • 1.6.4 Europe RNAi Technologies Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific RNAi Technologies Market Size and Prospect (2019-2030)
    • 1.6.6 South America RNAi Technologies Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa RNAi Technologies Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Alnylam Pharmaceuticals
    • 2.1.1 Alnylam Pharmaceuticals Details
    • 2.1.2 Alnylam Pharmaceuticals Major Business
    • 2.1.3 Alnylam Pharmaceuticals RNAi Technologies Product and Solutions
    • 2.1.4 Alnylam Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
  • 2.2 Benitec Biopharma Ltd
    • 2.2.1 Benitec Biopharma Ltd Details
    • 2.2.2 Benitec Biopharma Ltd Major Business
    • 2.2.3 Benitec Biopharma Ltd RNAi Technologies Product and Solutions
    • 2.2.4 Benitec Biopharma Ltd RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Benitec Biopharma Ltd Recent Developments and Future Plans
  • 2.3 Filmtec Corporation
    • 2.3.1 Filmtec Corporation Details
    • 2.3.2 Filmtec Corporation Major Business
    • 2.3.3 Filmtec Corporation RNAi Technologies Product and Solutions
    • 2.3.4 Filmtec Corporation RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Filmtec Corporation Recent Developments and Future Plans
  • 2.4 Ionis Pharmaceuticals
    • 2.4.1 Ionis Pharmaceuticals Details
    • 2.4.2 Ionis Pharmaceuticals Major Business
    • 2.4.3 Ionis Pharmaceuticals RNAi Technologies Product and Solutions
    • 2.4.4 Ionis Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Ionis Pharmaceuticals Recent Developments and Future Plans
  • 2.5 Quark Pharmaceuticals Inc.
    • 2.5.1 Quark Pharmaceuticals Inc. Details
    • 2.5.2 Quark Pharmaceuticals Inc. Major Business
    • 2.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Product and Solutions
    • 2.5.4 Quark Pharmaceuticals Inc. RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Quark Pharmaceuticals Inc. Recent Developments and Future Plans
  • 2.6 RXI Pharmaceuticals
    • 2.6.1 RXI Pharmaceuticals Details
    • 2.6.2 RXI Pharmaceuticals Major Business
    • 2.6.3 RXI Pharmaceuticals RNAi Technologies Product and Solutions
    • 2.6.4 RXI Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 RXI Pharmaceuticals Recent Developments and Future Plans
  • 2.7 Qiagen
    • 2.7.1 Qiagen Details
    • 2.7.2 Qiagen Major Business
    • 2.7.3 Qiagen RNAi Technologies Product and Solutions
    • 2.7.4 Qiagen RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Qiagen Recent Developments and Future Plans
  • 2.8 Invitrogen
    • 2.8.1 Invitrogen Details
    • 2.8.2 Invitrogen Major Business
    • 2.8.3 Invitrogen RNAi Technologies Product and Solutions
    • 2.8.4 Invitrogen RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Invitrogen Recent Developments and Future Plans
  • 2.9 Ambion
    • 2.9.1 Ambion Details
    • 2.9.2 Ambion Major Business
    • 2.9.3 Ambion RNAi Technologies Product and Solutions
    • 2.9.4 Ambion RNAi Technologies Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Ambion Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global RNAi Technologies Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of RNAi Technologies by Company Revenue
    • 3.2.2 Top 3 RNAi Technologies Players Market Share in 2023
    • 3.2.3 Top 6 RNAi Technologies Players Market Share in 2023
  • 3.3 RNAi Technologies Market: Overall Company Footprint Analysis
    • 3.3.1 RNAi Technologies Market: Region Footprint
    • 3.3.2 RNAi Technologies Market: Company Product Type Footprint
    • 3.3.3 RNAi Technologies Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global RNAi Technologies Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global RNAi Technologies Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global RNAi Technologies Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global RNAi Technologies Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America RNAi Technologies Consumption Value by Type (2019-2030)
  • 6.2 North America RNAi Technologies Consumption Value by Application (2019-2030)
  • 6.3 North America RNAi Technologies Market Size by Country
    • 6.3.1 North America RNAi Technologies Consumption Value by Country (2019-2030)
    • 6.3.2 United States RNAi Technologies Market Size and Forecast (2019-2030)
    • 6.3.3 Canada RNAi Technologies Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico RNAi Technologies Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe RNAi Technologies Consumption Value by Type (2019-2030)
  • 7.2 Europe RNAi Technologies Consumption Value by Application (2019-2030)
  • 7.3 Europe RNAi Technologies Market Size by Country
    • 7.3.1 Europe RNAi Technologies Consumption Value by Country (2019-2030)
    • 7.3.2 Germany RNAi Technologies Market Size and Forecast (2019-2030)
    • 7.3.3 France RNAi Technologies Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom RNAi Technologies Market Size and Forecast (2019-2030)
    • 7.3.5 Russia RNAi Technologies Market Size and Forecast (2019-2030)
    • 7.3.6 Italy RNAi Technologies Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific RNAi Technologies Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific RNAi Technologies Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific RNAi Technologies Market Size by Region
    • 8.3.1 Asia-Pacific RNAi Technologies Consumption Value by Region (2019-2030)
    • 8.3.2 China RNAi Technologies Market Size and Forecast (2019-2030)
    • 8.3.3 Japan RNAi Technologies Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea RNAi Technologies Market Size and Forecast (2019-2030)
    • 8.3.5 India RNAi Technologies Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia RNAi Technologies Market Size and Forecast (2019-2030)
    • 8.3.7 Australia RNAi Technologies Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America RNAi Technologies Consumption Value by Type (2019-2030)
  • 9.2 South America RNAi Technologies Consumption Value by Application (2019-2030)
  • 9.3 South America RNAi Technologies Market Size by Country
    • 9.3.1 South America RNAi Technologies Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil RNAi Technologies Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina RNAi Technologies Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa RNAi Technologies Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa RNAi Technologies Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa RNAi Technologies Market Size by Country
    • 10.3.1 Middle East & Africa RNAi Technologies Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey RNAi Technologies Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia RNAi Technologies Market Size and Forecast (2019-2030)
    • 10.3.4 UAE RNAi Technologies Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 RNAi Technologies Market Drivers
  • 11.2 RNAi Technologies Market Restraints
  • 11.3 RNAi Technologies Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 RNAi Technologies Industry Chain
  • 12.2 RNAi Technologies Upstream Analysis
  • 12.3 RNAi Technologies Midstream Analysis
  • 12.4 RNAi Technologies Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on RNAi Technologies. Industry analysis & Market Report on RNAi Technologies is a syndicated market report, published as Global RNAi Technologies Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of RNAi Technologies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,693.52
    4,040.28
    5,387.04
    3,194.64
    4,791.96
    6,389.28
    548,030.40
    822,045.60
    1,096,060.80
    291,450.00
    437,175.00
    582,900.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report